HALOG (Ranbaxy Laboratories Inc.)


Welcome to the PulseAid listing for the HALOG drug offered from Ranbaxy Laboratories Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Ranbaxy Laboratories Inc.
NON-PROPRIETARY NAME: HALCINONIDE
SUBSTANCE NAME: HALCINONIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-05-19
END MARKETING DATE: 0000-00-00


HALOG HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHALOG from Ranbaxy Laboratories Inc.
LABELER NAME: Ranbaxy Laboratories Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/g)
START MARKETING DATE: 2009-05-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 10631-096_4f4aa443-ad0c-4358-88a8-97bcee07cd3b
PRODUCT NDC: 10631-096
APPLICATION NUMBER: NDA017824

Other HALCINONIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
E.R. Squibb & Sons, L.L.C.HALOG
Ranbaxy Laboratories IncHalog
Ranbaxy Laboratories Inc.HALOG